Medigus Announces The Global Commercial Launch of The Next Generation of The MUSE™ System for the Long-term Treatment of GERD

OMER, Israel, June 14, 2016 — Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced the global launch of the newest technological generation of the Medigus Ultrasonic Surgical Endostapler, or MUSE™ system. The MUSE system is a leading minimally-invasive option for the long-term treatment of GERD (gastroesophageal reflux disease), one of the most common chronic conditions in the world. Now in its seventh generation, system updates offer physicians enhanced usability through an improved ultrasound algorithm, a redesigned distal tip and enhanced software.

“Our newest generation of MUSE offers gastroenterologists enhanced capability through cutting-edge advancements in microvisual, ultrasonic and endostapling technology, allowing them to perform transoral fundoplication with a more advanced system and improved usability,” said Chris Rowland, CEO of Medigus.

System features that have been updated include:
• A redesigned distal tip to allow for easier insertion
• An improved console which now supports carbon dioxide insulation, allowing for quicker absorption
• An enhanced ultrasound algorithm, which enables a more streamlined procedure
• A refined GUI (Graphic User Interface), which enables more effective transmission of information from the device to the console

“I am pleased to introduce the technologically enhanced MUSE in my practice, as I believe the system offers unique benefits over existing therapies in GERD management,” said Dr. Shinil Shah, DO, General Surgeon at Memorial Hermann. “In my experience, transoral fundoplication with MUSE is a safe alternative to invasive surgery and may be the preferred method by patients who are looking for a long-term solution for their troublesome reflux symptoms.”

Since its introduction, several transoral fundoplication procedures have been performed with the Gen 7 MUSE system by leading healthcare institutions, including Indiana University Health, Memorial Hermann and Borland-Groover Clinic.

Learn more about the MUSE system at

About The MUSE™ System
The MUSE™ system is a leading technology in Transoral Fundoplication (TF) procedures. The system allows a single physician or surgeon to perform anterior partial fundoplication with standard surgical staples in a less invasive way, compared to other surgical procedures. The intuitive endosurgical platform consists of a single use flexible surgical endostapler, equipped with a proprietary miniature camera, an ultrasonic sight and a range finder. The endostapler includes a handle with controls, an 80cm flexible shaft, a 5 cm rigid section holding a cartridge with 5 standard 4.8 mm titanium surgical staples, a ratchet controlled one-way articulating section, and a distal tip. The MUSE system is FDA cleared and CE marked, and has also has obtained the necessary licenses to market the product in Canada and Israel. For more information, visit